Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_BaseE_MultiLocus]

ABSTRACT: Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_BaseE_MultiLocus]

PROVIDER: PRJNA1001265 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25490300.fastq.gz	Fastqsanger.gz
	SRR25490400.fastq.gz	Fastqsanger.gz
	SRR25490301.fastq.gz	Fastqsanger.gz
	SRR25490401.fastq.gz	Fastqsanger.gz
	SRR25490302.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 149

Similar Datasets

Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_BaseE_MultiLocus]

2023-08-02 | GSE239852 | GEO

Genotoxic effects of base and prime editing in human hematopoietic stem cells [BARseq_BaseE]

2023-07-18 | GSE220753 | GEO

Genotoxic effects of base and prime editing in human hematopoietic stem cells [RNAseq_PrimeEd]

2023-07-18 | GSE218463 | GEO

Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_PrimeE]

2023-07-18 | GSE220765 | GEO

Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_BaseE]

2023-07-18 | GSE220763 | GEO

Genotoxic effects of base and prime editing in human hematopoietic stem cells [RNAseq_BaseEd]

Project description:Emerging base and prime editing may provide safer and more precise genetic engineering than nuclease-based approaches bypassing the dependence on DNA double strand breaks (DSBs). However, little is known about cellular responses and genotoxicity. Here, we comparatively assessed state-of-the-art base and prime editors (B/PE) versus Cas9 in human hematopoietic stem/progenitor cells (HSPCs). BE and PE induced detrimental transcriptional responses constraining editing efficiency and/or HSPC repopulation in xenotransplants, albeit to a lesser extent than Cas9. DNA DSBs and their genotoxic byproducts, including deletions and translocations, were less frequent but not abrogated by BE and PE, particularly for cytidine BE due to suboptimal inhibition of base excision repair. Tailoring timing and B/PE expression enabled highly efficient and precise editing of long-term repopulating HSPCs. However, we uncovered a genome-wide effect of BEs on the mutational landscape of HSPCs, raising concerns for a potential genotoxic impact and calling for further investigations and improvements in view of clinical application.and/or HSPC repopulation in xenotransplants, albeit to a lesser extent than Cas9. DNA DSBs and their genotoxic byproducts, including deletions and translocations, were lower but not abrogated by BE and PE, particularly for cytidine BE upon suboptimal base excision repair inhibition. Tailoring timing and B/PE expression enabled highly efficient and precise editing of long-term repopulating HSPCs. However, we uncovered a genome-wide effect of cytidine BE on mutational landscape of hematopoietic grafts, raising concerns for its prospective clinical application. Conversely, the superior efficiency and precision of adenine BE built confidence on its entry into clinical arena.

2023-07-18 | GSE218462 | GEO

Genotoxic effects of base and prime editing in human hematopoietic stem cells

Project description:Genotoxic effects of base and prime editing in human hematopoietic stem cells

| PRJNA903895 | ENA

Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_BaseE]

Project description:Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_BaseE]

| PRJNA911288 | ENA

Genotoxic effects of base and prime editing in human hematopoietic stem cells [RNAseq_PrimeEd]

Project description:Genotoxic effects of base and prime editing in human hematopoietic stem cells [RNAseq_PrimeEd]

| PRJNA903898 | ENA

Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_PrimeE]

Project description:Genotoxic effects of base and prime editing in human hematopoietic stem cells [NHEJ_PrimeE]